Challenges and opportunities for HSCT outcome registries: Perspective from international HSCT registries experts

Bone Marrow Transplantation

Volumn 49, Issue 8, 2014, Pages 1016-1021

  Aljurf, M ^a   Rizzo, J D ^b   Mohty, M ^c   Hussain, F ^a   Madrigal, A ^d   Pasquini, M C ^b   Passweg, J ^e   Chaudhri, N ^a   Ghavamzadeh, A ^f   Solh, H E ^a   Atsuta, Y ^g   Szer, J ^h   Kodera, Y ⁱ   Niederweiser, D ^e   Gratwohl, A ^j   Horowitz, M M ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^c HÔPITAL SAINT ANTOINE   (France)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h ROYAL MELBOURNE HOSPITAL   (Australia)

ⁱ AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MULTICENTER STUDY (TOPIC); REGISTER;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTICENTER STUDIES AS TOPIC; REGISTRIES;

EID: 84905686615     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.78     Document Type: Review

References (24)

1. Gliklich, RE Dreyer, NA (eds). Registries for Evaluating Patient Outcomes: A User's Guide. 2nd edn Agency for Healthcare Research and Quality: Rockville, MD, USA, 2010. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA290200500351 TO3.) AHRQ Publication No. 10-EHC049.
2. Horowitz MM. The role of registries in facilitating clinical research in bmt: examples from the center for international blood and marrow transplant research. Bone Marrow Transplantation 2008; 42: S1-S2.
3. Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE et al. Tacrolimus vs cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. Biol Blood Marrow Transplant 1999; 5: 180-186.
4. Russell NH, Szydlo R, McCann S, Potter MN, Craddock C, Towlson K et al. British Society for Blood and Marrow Transplantation. The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland. Br J Haematol 2004; 124: 499-503.
5. For-Patients and Families/Getting a transplant/Choosing a transplant center/US transplant centers. http://www.bethematch.org (accessed 29 December, 2013).
6. CIBMTR Center-Specific Outcomes Analysis. http://www.cibmtr.org/Meetings/ Materials/CSOAForum/Pages/index.aspx (accessed 10 December, 2013).
7. Kodera Y. The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry. Bone Marrow Transplant 2008; 42: S6.
8. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 2007; 86: 269-274.
9. Silberman G, Crosse MG, Peterson EA, Weston RC, Horowitz MM, Appelbaum FR et al. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. New Engl J Med 1994; 331: 1063-1067.
10. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Fernando- Bouzas L, Yoshimi A et al. Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
11. Health Information Privacy and Public Health, US Department of Health and Human Services. http://www.hhs.gov/ocr/privacy/hipaa/understanding/special/ publichealth/ (accessed 29 December, 2013).
12. FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration, Fourth Edition. http://www. factwebsite.org/uploadedFiles/ FACT-News/ Final%20Draft%205th%20Edition%20Accreditation% 20Manual.04.18.11.pdf (accessed 29 December, 2013).
13. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
14. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005; 11: 945-956.
15. Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT et al. Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biol Blood Marrow Transplant 2010; 16: 1076-1083.
16. Locatelli F, Crotta A, Ruggeri A, Eapen M, Wagner JE, Macmillan ML et al. Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood 2013; 122: 2135-2141.
17. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653-660.
18. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J et al. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011; 17: 1375-1382.
19. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175-1183.
20. Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268: 607-612.
21. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 2001; 27: 689-692.
22. Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM et al. Providing personalized prognostic information for adult leukemia survivors. Biol Blood Marrow Transplant 2013; 19: 1600-1607.
23. Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014; 123: 133-140.
24. Jacobsohn DA, Arora M, Klein JP, Hassebroek A, Flowers ME, Cutler CS et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood 2011; 118: 4472-4479